_edited.jpg

Welcome To The World Of Plant Therapeutics

Planting The Seeds For A Better Future

 

TECHNOLOGY

Advantages of plant-based systems for producing vaccines and therapeutic proteins

  • There is low risk of cross-contamination with human/animal viruses, pathogens, prions and oncogenic DNAs

  • High quality complex proteins can be produced

  • Short production time scale (3-4 weeks); useful in emergencies (new viral outbreak)

  • Quick up-scaling

  • System can be quickly updated for mutations occurring in viral genome

  • High consumer acceptance

  • Low overall cost

tissue - Copy.png
 
Vaccine

VACCINES

A vaccine is a biological preparation that elicit immune response similar to a virus or bacterial pathogen leading to development of active acquired immunity


      Vaccine types

  • Virus-like particles (VLPs) lacking core genomic sequence

  • Protein sub-unit (e.g. surface protein)

 

Bologics and Biosimilars

Biologics are a variety of products made in living cells that includes therapeutic proteins, monoclonal antibodies and vaccines. They cure or prevent many diseases and complex conditions including cancer, diabetes, cystic fibrosis, rheumatoid athritis and immune disorders.

       Market potential

  • The world Biologics market is worth $ 255 billion, where as the biosimilar market is around $ 11.8 billion

  • Biosimilar market is projected to reach $ 240 billion by 2030 

  • Indian biosimilar market to go from current $2.2 billion to $35 billion by 2030 (Assocham)

Embryonic Stem Cells
 

Our Team

Dr. Neelendra Kumar

Founder/CEO

Dr. Kumar is the scientific brain behind the company. He has vast experience in fields of molecular biology, production of transgenic plants and plant biotechnology.

  • Doctorate in natural sciences, Justus Liebig University Giessen, Germany

  • Guest researcher at MPI-Terrestrial Microbiology, Germany

  • Masters in Agrobiotechnology, Justus Liebig University Giessen, Germany

  • Bachelors (Hons.) in Microbiology, Sam Higginbottom University of Agriculture Technology And Sciences, India

Dr. Subhash Balakrishnan Pai

Co-Founder/COO

Dr. Pai brings brings with him vast experience and knowledge of protein biochemistry and plant genetics.  Having worked in a plant biotechnology company before, Dr. Pai takes care of the business and regulatory aspects of the company

  • Doctorate in natural sciences, Justus Liebig University Giessen, Giessen, Germany

  • Research stay as visiting scholar at Cornell University, Ithaca NY, USA.

  • Industrial internship at BASF SE, crop protection, Limburgerhof, Germany

  • Masters in Agrobiotechnology, Justus Liebig University Giessen, Giessen, Germany

  • Bachelors in Biotechnology, Bangalore University, Bangalore, India

 

Get in Touch

Agrovac Biotech Private Limited

No. 677, Suite#244, 1st Floor,
27th Main, 13th Cross,
HSR Layout, Bangalore - 560102
Karnataka, India

0484-2518333

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
Experiment
 

©2020 by Agrovac Technologies.